The IPO Buzz: Parabilis Therapeutics (PBLS Proposed) Upsizes IPO by 1/3 to $600 Million
Parabilis Therapeutics announced an IPO upsizing to 33.33 million shares, keeping a $17‑$19 price range and targeting roughly $600 million if priced at the $18 midpoint. The offering, led by Leerink Partners and BofA Securities with Evercore ISI, Guggenheim and LifeSci Capital, is slated to price after market close on June 9 and trade on Nasdaq the next day. The company disclosed a pending $75 million Regeneron private placement at 90 percent of the IPO price and plans a Phase 3 registrational trial of zolucatetide for desmoid tumors in early 2027. Parabilis reported a $152.9 million net loss for the year ended March 31, 2026, with no revenue.
The IPO Buzz: WhiteHawk Minerals (WHK) Upsizes IPO & Prices It at $26 Mid-Point
WhiteHawk Minerals, a natural‑gas mineral and royalty interests firm, upsized its IPO to 7.7 million shares at $26 per share—the midpoint of its $25‑$27 range—raising roughly $200.2 million. The offering, led by Raymond James and Stifel, will begin trading on the New York...
The IPO Buzz: OpenAi Says It’s Filed a Confidential S-1 with the SEC
OpenAI announced it has submitted a confidential S‑1 filing with the SEC, invoking Rule 135 to test market interest while keeping details private. The company said the filing could leak, prompting the early disclosure, but it has not set a definitive...
The IPO Buzz: INNIO (INIO) Jumps in NASDAQ Debut After Big Upsizing
INNIO Holding debuted on Nasdaq at $31 per share, a 14.8% premium over its $27 IPO price, after upsizing the offering to 90 million shares and raising roughly $2.43 billion. The secondary‑sale IPO, led by Goldman Sachs, J.P. Morgan and Morgan Stanley,...
The IPO Buzz: SpaceX (SPCX Proposed) Sets $135/Share IPO Price to Raise $75 Billion
SpaceX filed its S‑1/A on June 3, setting the IPO price at $135 per share and targeting a $75 billion raise. The offering would consist of 555.56 million shares, valuing the company at roughly $1.8 trillion post‑pricing. Goldman Sachs and Morgan Stanley are...
The IPO Buzz: Applied Aerospace & Defense (AADX Proposed) Sets Terms for $634 Mln IPO
Applied Aerospace & Defense (AADX), a Huntsville‑based aerospace and defense services firm backed by Greenbriar Equity, filed an S‑1/A outlining a 32.5 million‑share IPO priced between $18.00 and $21.00. If priced at the $19.50 midpoint, the offering would raise about $633.8 million...
The IPO Buzz: Innio (INIO Proposed) Unveils $1.9 Billion IPO
German‑based Innio Holding announced a proposed IPO of 75 million shares priced between $24 and $27, targeting up to $1.91 billion in gross proceeds. At the midpoint of $25.50, the offering would imply a market valuation of roughly $19.1 billion. The sole selling...
The IPO Buzz: Quantinuum (QNT Proposed) Launches $1 Billion IPO
Quantinuum, a quantum‑computing spin‑out of Honeywell, filed a $1 billion IPO prospectus on May 26, 2026, offering 21.05 million shares at $45‑$50 each, implying a $12.06 billion market cap at the $47.50 midpoint. Lead managers are J.P. Morgan and Morgan Stanley, with a slate of...
The IPO Buzz: Lincoln International (LCLN) Prices IPO at $20 – Top of Range
Lincoln International priced its IPO at the top of the range, $20 per share, selling 21.05 million shares to raise $421 million. The offering gave the firm a market capitalization of about $2.04 billion as it prepares to debut on the New York...
The IPO Buzz: Lincoln International (LCLN Proposed) On Tap as SpaceX Mania Revs Up
Lincoln International, a Chicago‑based investment‑banking advisory firm, is set to go public on the NYSE this week. The IPO will offer 21.05 million shares at $18‑$20 each, targeting roughly $400 million in proceeds if priced at the $19 midpoint. The company posted...
The IPO Buzz: GMR Solutions Prices IPO at $15 – Big Price Cut – & Stock Sinks on the...
GMR Solutions priced its initial public offering at $15 per share, a steep cut from the original $22‑$25 range, and sold 31.91 million shares to raise roughly $479 million, valuing the company at about $3.4 billion. The Dallas‑Fort Worth‑based EMS leader opened on...
The IPO Buzz: Fervo Energy Prices IPO at $27 – $1 Above Range – & Stock Surges on NASDAQ
Fervo Energy priced its IPO at $27 per share, $1 above the top of the indicated range, raising $1.89 billion and valuing the company at about $7.7 billion. The stock surged roughly 35 percent on debut, closing at $36.54. Fervo develops enhanced geothermal...
The IPO Buzz: AI Chipmaker Cerebras (CBRS Proposed) Leads $7.4 Billion Week
Cerebras Systems, the AI chipmaker known for its massive silicon‑wafer processor, is set to lead a $7.43 billion IPO week. The company plans to price its shares between $125 and $135, with market chatter suggesting a possible $150‑$160 range, which would...
The IPO Buzz: Odyssey Therapeutics Prices Upsized IPO at $18 – Stock Pops & Drops
Odyssey Therapeutics priced its IPO at the top of the $16‑$18 range, selling 15.5 million shares for $18 each and raising roughly $279 million. The Boston‑based biotech debuted on Nasdaq at $20, an 11% first‑day gain, before slipping back to the issue...
The IPO Buzz: Suja Life Prices IPO at $21 – Low End – Set for NASDAQ Debut Today
Suja Life priced its initial public offering at $21 per share, the low end of its guidance, and sold the full 8.89 million shares authorized in the prospectus, raising roughly $186.7 million. The offering, led by Goldman Sachs and Jefferies, will debut...